{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:14:36Z","timestamp":1791188076161,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1989,6]]},"abstract":"<jats:p>\n                    C57BL\/6 mice bearing either a transplantable methylcholanthrene\u2010induced sarcoma or Lewis lung adenocarcinoma were passively immunized every other day with a rabbit immunoglobulin fraction raised against murine cachectin\/tumor necrosis factor\u2010\u03b1. Mice bearing methylcholanthrene\u2010induced sarcoma developed tumor\u2010associated hypophagia that was attenuated by anticachectin immunoglobulin treatment. In the same tumor\u2010bearing animals, anticachectin treatment also significantly reduced the extent of carcass protein and fat loss, and reduced tumor weight. Mice bearing Lewis lung adenocarcinoma did not develop significant anorexia or carcass lean tissue depletion as tumor growth progressed, but they lost carcass lipid. Treatment of Lewis lung adenocarcinoma\u2010bearing mice with anticachectin antibodies diminished the degree of carcass lipid depletion and prevented plasma hypertriglyceridemia. However, in both tumor models, anti\u2010cachectin treatment did not affect either the development of anemia, hypoalbuminemia or the increase in serum amyloid P concentrations seen with increasing tumor burden. We conclude that an endogenous cachectin response, inhibitable by exogenously administered antibody, contributes to anorexia and to changes in body fat and protein metabolism in these tumor\u2010bearing animals. Neutralizing endogenous cachectin production with antibodies offers the potential to reduce tissue wasting that is frequently associated with neoplastic disease, but it does not appear to affect all of the hematologic and acute phase responses in these murine tumor models.\u2014 S\n                    <jats:sc>herry<\/jats:sc>\n                    , B. A.; G\n                    <jats:sc>elin<\/jats:sc>\n                    , J.; F\n                    <jats:sc>ong<\/jats:sc>\n                    , Y.; M\n                    <jats:sc>arano<\/jats:sc>\n                    , M.; W\n                    <jats:sc>ei<\/jats:sc>\n                    , H.; C\n                    <jats:sc>erami<\/jats:sc>\n                    , A.; L\n                    <jats:sc>owry<\/jats:sc>\n                    , S. F.; L\n                    <jats:sc>undholm<\/jats:sc>\n                    , K. G.; M\n                    <jats:sc>oldawer<\/jats:sc>\n                    , L. L. Anticachectin\/tumor necrosis factor\u2010\u03b1 antibodies attenuate development of cachexin in tumor models.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    3: 1956\u20101962; 1989.\n                  <\/jats:p>","DOI":"10.1096\/fasebj.3.8.2721856","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T07:25:01Z","timestamp":1516260301000},"page":"1956-1962","source":"Crossref","is-referenced-by-count":155,"title":["Anticachectin\/tumor necrosis factor\u2010\u03b1 antibodies attenuate development of cachexia in tumor models"],"prefix":"10.1096","volume":"3","author":[{"given":"Barbara A.","family":"Sherry","sequence":"first","affiliation":[{"name":"The Laboratory of Medical Biochemistry The Rockefeller University New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gelin","sequence":"additional","affiliation":[{"name":"Surgical Metabolism Laboratory Department of Surgery I Sahlgren's Hospital University of Gothenburg Gothenburg Sweden S431 45"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuman","family":"Fong","sequence":"additional","affiliation":[{"name":"The Laboratory of Surgical Metabolism Department of Surgery The New York Hospital Cornell University Medical College New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Marano","sequence":"additional","affiliation":[{"name":"The Laboratory of Surgical Metabolism Department of Surgery The New York Hospital Cornell University Medical College New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wei","sequence":"additional","affiliation":[{"name":"The Laboratory of Surgical Metabolism Department of Surgery The New York Hospital Cornell University Medical College New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Cerami","sequence":"additional","affiliation":[{"name":"The Laboratory of Medical Biochemistry The Rockefeller University New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Lowry","sequence":"additional","affiliation":[{"name":"The Laboratory of Surgical Metabolism Department of Surgery The New York Hospital Cornell University Medical College New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent G.","family":"Lundholm","sequence":"additional","affiliation":[{"name":"Surgical Metabolism Laboratory Department of Surgery I Sahlgren's Hospital University of Gothenburg Gothenburg Sweden S431 45"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle L.","family":"Moldawer","sequence":"additional","affiliation":[{"name":"The Laboratory of Surgical Metabolism Department of Surgery The New York Hospital Cornell University Medical College New York New York 10021 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1989,6]]},"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.3.8.2721856","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.3.8.2721856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:49:37Z","timestamp":1761688177000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.3.8.2721856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["10.1096\/fasebj.3.8.2721856"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.3.8.2721856","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}